Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- Collagen Nutraceuticals files for Worldwide Patent Protection on HA Extraction Process and Biofermentation Source
announces the filing of worldwide patent protection for their rooster and hen’s comb HA extraction process and biofermentation method, utlizied in manufacturing PureHA(TM).
- Collagen Nutraceuticals files for Worldwide Patent Protection on HA Extraction Process and Biofermentation Source
announces the filing of worldwide patent protection for their rooster and hen’s comb HA extraction process and biofermentation method, utlizied in manufacturing PureHA(TM).
- Collagen Nutraceuticals files for Worldwide Patent Protection on HA Extraction Process and Biofermentation Source
announces the filing of worldwide patent protection for their rooster and hen’s comb HA extraction process and biofermentation method, utlizied in manufacturing PureHA(TM).
- Collagen Nutraceuticals files for Worldwide Patent Protection on HA Extraction Process and Biofermentation Source
announces the filing of worldwide patent protection for their rooster and hen’s comb HA extraction process and biofermentation method, utlizied in manufacturing PureHA(TM).
- Patent Issued for SLIMALUMA
Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same."
- Patent Issued for SLIMALUMA
Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same."
- Patent Issued for SLIMALUMA
Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same."
- Patent Issued for SLIMALUMA
Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same."
- Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product
Company announces it has been granted an invention patent (ZL03119221.1) on its Jutai soft capsules product containing American Ginseng and Echinacea, with patent protection over the methods of product preparation, utility as well as methods of quality control.
- Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product
Company announces it has been granted an invention patent (ZL03119221.1) on its Jutai soft capsules product containing American Ginseng and Echinacea, with patent protection over the methods of product preparation, utility as well as methods of quality control.
- Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product
Company announces it has been granted an invention patent (ZL03119221.1) on its Jutai soft capsules product containing American Ginseng and Echinacea, with patent protection over the methods of product preparation, utility as well as methods of quality control.
- Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product
Company announces it has been granted an invention patent (ZL03119221.1) on its Jutai soft capsules product containing American Ginseng and Echinacea, with patent protection over the methods of product preparation, utility as well as methods of quality control.
- Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product
Company announces it has been granted an invention patent (ZL03119221.1) on its Jutai soft capsules product containing American Ginseng and Echinacea, with patent protection over the methods of product preparation, utility as well as methods of quality control.
- NutraCea Continues to Expand Its International Patent Portfolio
Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655.
- NutraCea Continues to Expand Its International Patent Portfolio
Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655.
- NutraCea Continues to Expand Its International Patent Portfolio
Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655.
- Austrian Court Upholds Novogen Patent for Red Clover Isoflavones
Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld.
- Austrian Court Upholds Novogen Patent for Red Clover Isoflavones
Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld.
- Austrian Court Upholds Novogen Patent for Red Clover Isoflavones
Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Nutrition Formulators, Inc. Completes Its First Generation of Fast Dissolving Supplements
Company has developed an innovative line of fast dissolving tablets for dietary supplements.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Martek Announces New Infant Formula Licensee
Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- Notice of Request for Proposals for Stevia rebaudiana Cultivars
Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- New Patent Promotes Soy Isoflavone Benefits
The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity
Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Provexis Announces Exclusivity Agreement
Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market
Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient
Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration. This joint venture will enable better utilization of the companies’ capabilities and reinforce their ongoing cooperation. It is based on exclusive isolation of esters from marigold flower. Bayer Pharma has registered a patent for a natural OTC product worldwide based on marigold flower extracts.
"This agreement with a leading pharmaceutical company represents a significant step for Vitiva," says Ohad Cohen, CEO of Vitiva. “Both partners, Bayer and Vitiva have made major investments to ensure the success of this venture. This collaboration will stimulate development of innovative products and will deliver new solutions for consumers who prefer to use natural ingredients – an area in which Vitiva has earned an excellent reputation. We look forward to the opportunity to work together and are confident that this agreement will lay the foundation for ongoing cooperation between Bayer Pharma and Vitiva.”
Vitiva has made repeated investments in its manufacturing facility to meet Bayer Pharma’s strict standards and requirements for high quality products and on-time delivery. “Vitiva was chosen by Bayer Pharma for its advanced technologies and facilities and its expertise in the isolation of high-value natural extracts,” says Mr. Matjaz Mohar, supply chain manager at Bayer Pharma. “This agreement acknowledges that cutting-edge natural products and intellectual property protection are the foundation for the growth and success of our industry. Vitiva, a leading global supplier of natural rosemary antioxidants, has a strong commitment to serving its customers through innovation and high quality products.”
Bayer Pharmaceuticals Corporation is part of the new Global Pharmaceutical Division, established January 1, 2006. It grew out of the former Biological Products and Pharmaceutical Division and now comprises three business units: Hematology/Cardiology, Oncology and Primary Care. Bayer HealthCare AG employed 33,800 people worldwide in 2005. Bayer Pharmaceutical Division's high-quality drug products have helped patients lead healthier lives. To continue improving human health worldwide, the company’s researchers seek innovative treatments for different diseases.
Vitiva is a dynamic, fast-growing nutraceuticals company offering natural extracts and a full range of deodorized rosemary extracts indifferent concentrations. These pure extracts are soluble in oil and water, and available in powder and liquid forms.
For more information please contact:
Mr. Ohad Cohen, CEO
Tel: +386217888738
E-mail: service@vitiva.si
www.vitiva.si
|